{"id":473705,"date":"2021-04-08T09:33:19","date_gmt":"2021-04-08T13:33:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=473705"},"modified":"2021-04-08T09:33:19","modified_gmt":"2021-04-08T13:33:19","slug":"pavmed-to-present-at-the-20th-annual-needham-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/","title":{"rendered":"PAVmed to Present at the 20th Annual Needham Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, April  08, 2021  (GLOBE NEWSWIRE) &#8212; <strong>PAVmed Inc. (Nasdaq: PAVM, PAVMZ<\/strong>) (the \u201cCompany\u201d or \u201cPAVmed\u201d), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed\u2019s Chairman and Chief Executive Officer will present a corporate update at the 20th Annual Needham Healthcare Conference on April 15, 2021 at 8:00 AM EDT.<\/p>\n<p align=\"justify\">To access the live webcast of the presentation, please <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ePQlinzHk8jCFWatZa-aeQxukP1tI5pzzD51rOzRq3QMxJmK3cypIavZmXCvxtHQo2FOcP16k0OrEiYypa5l-crjlxGSqcV6DymdrmLNAdA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">click here<\/a>. A replay will be available following the presentation and can be accessed in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rd_Z_pOFO7MRmUA_SoJI4iGJ0QyJw5aqc9RA1dByVObDCreaGTMgdzmtDclfOvoBdEQrrAO_9ZX--ruc2pTCbQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Investor Relations<\/a> section of the PAVmed website.<\/p>\n<p align=\"justify\">\n        <strong>About PAVmed<\/strong><br \/>\n        <br \/>PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company employing a unique business model designed to advance innovative products to commercialization rapidly and with less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation while seeking to further expand its pipeline through relationships with its network of clinician innovators at leading academic centers. PAVmed\u2019s diversified product pipeline addresses unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its four operating divisions include GI Health (EsoGuard<sup>\u00ae<\/sup> Esophageal DNA Test, EsoCheck<sup>\u00ae<\/sup> Esophageal Cell Collection Device, and EsoCure<sup>\u2122<\/sup> Esophageal Ablation Device with Caldus<sup>\u2122<\/sup> Technology), Minimally Invasive Interventions (CarpX<sup>\u00ae<\/sup> Minimally Invasive Device for Carpal Tunnel Syndrome), Infusion Therapy (PortIO<sup>\u2122<\/sup> Implantable Intraosseus Vascular Access Device and NextFlo<sup>\u2122<\/sup> Highly Accurate Disposable Intravenous Infusion Set), and Emerging Innovations (non-invasive laser-based glucose monitoring, pediatric ear tubes, and mechanical circulatory support). For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2r578u00xDR3Nx5c5RcLXO1f-GKDqaxfin131DpvIY6adamOL1zqinHSKGnJssQVP92ukTLsKDYhx9ZKNzh3sg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.pavmed.com<\/a>, follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=px1UcZIYr29or9YWNjP9lQvTLJ27tXH0QyyXHTP7sGURuQKyS5M2qRNvQM_w9wYdYWBrq1V9zWHt7YAsXot5Lg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Twitter<\/a>, connect with us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C4XOIbgcDaunVSTtdWYxQYkZaW85WlcVuvA-9BoOm33yq5WID4T9UXFEMurwFuMM_-9hkrqCg2VQW4QDh9RscbAr2yfy7HfaoiW4kvC2-Ls=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>, and watch our videos on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GrSXu7CflXG1OfJh62OcHI3XzaSVkTlomwIuPaDHcdT9i3UjWArFaitY8QbyIiSBknmSirHRNBU2CbntyYE11TzBPAM3Zq1HwseUTS7ewIRiASsdpFMVGnymAWzHKjwE\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">YouTube<\/a>. For more information on our majority owned subsidiary, Lucid Diagnostics Inc., please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Pva3aeaJ2Fz8Dy74gG0WCsAwdh_8SaEywsqlbc2NsgQjHxFcbee3ixKX69SUbmE33ds5juLkwhNUnpJfmyfmeA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.luciddx.com<\/a>, follow Lucid on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=px1UcZIYr29or9YWNjP9lV-JjPVdO4HWFhhuh9TorqYhguSADwfmIUnQligmewinhhY67Vvic-oOeX8hVRNsHg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Twitter<\/a>, and connect with Lucid on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C4XOIbgcDaunVSTtdWYxQWKU-fKrS4noTvVn3C_yFf4OKFu3v7AZ-GfYqlHbclWiayc20eQt0fZ82NC7LWwr_FVYyvuGuE33YDdIi62G88Y=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>. For detailed information on EsoGuard, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cA6VymCdJwdJkjaUGK0381zfGCq0Oh91ur_mq7kNmRuNa39tkpS0BtIPt3zrxnOeqhUVaJuQEsfU3bOhoH5g7w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.EsoGuard.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=px1UcZIYr29or9YWNjP9lW5iK8nQAIB7RPLT3g0ZPNE86xntMZufaWdBA4E-K9o-r71wSl2zNk4XuoX8LdZ-lA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Twitter<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cfdXvwy2bCnMLP84buG3feRB10tUqnFqSBZsSXfEUYk0hpuxAB7sf3uf6IvhJJyQj9B2YnGgnN7LH-XHv5KHPg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Facebook<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OEgTDnv6zYKkMhVrwBn58TKg3bKMYCC20h35VYFlbiZwLAB5Rp5UX7uj5BMmkyr2SW3GhLbMURex_iDMHhqGqPjpcRVPQP4ol2dKRKMRoGE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, based upon the current beliefs and expectations of PAVmed\u2019s management, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Risks and uncertainties that may cause such differences include, among other things, volatility in the price of PAVmed\u2019s common stock, Series W Warrants and Series Z Warrants; general economic and market conditions; the uncertainties inherent in research and development, including the cost and time required advance PAVmed\u2019s products to regulatory submission; whether regulatory authorities will be satisfied with the design of and results from PAVmed\u2019s preclinical studies; whether and when PAVmed\u2019s products are cleared by regulatory authorities; market acceptance of PAVmed\u2019s products once cleared and commercialized; our ability to raise additional funding and other competitive developments. PAVmed has not yet received clearance from the FDA or other regulatory body to market many of its products. The Company has been monitoring the COVID-19 pandemic and its impact on our business. The Company expects the significance of the COVID-19 pandemic, including the extent of its effect on the Company\u2019s financial and operational results, to be dictated by, among other things, the success of efforts to contain it and the impact of actions taken in response. New risks and uncertainties may arise from time to time and are difficult to predict. All of these factors are difficult or impossible to predict accurately and many of them are beyond PAVmed\u2019s control. For a further list and description of these and other important risks and uncertainties that may affect PAVmed\u2019s future operations, see Part I, Item IA, \u201cRisk Factors,\u201d in PAVmed\u2019s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, as the same may be updated in Part II, Item 1A, \u201cRisk Factors\u201d in any Quarterly Report on Form 10-Q filed by PAVmed after its most recent Annual Report. PAVmed disclaims any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in its expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.<\/p>\n<p>\n        <strong>Contacts:<\/strong><br \/>\n        <br \/>\n        <u>Investors<\/u><br \/>\n        <br \/>Mike Havrilla<br \/>Director of Investor Relations<br \/>(814) 241-4138<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PDvLd0J-pIxqzj-se6kvWGXvxnX9iMG0JN7z37F9nZ35AKA7ZnpNlF7VSDYw4wWUrFwY91cfQaK7y7dXgjvMBg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">JMH@PAVmed.com<\/a><\/p>\n<p>\n        <u>Media<\/u><br \/>\n        <br \/>Shaun O\u2019Neil<br \/>Chief Commercial Officer<br \/>(518) 812-3087<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CM_nUXlm1nO-ti2cWWEMtmag2VisfgkSUWCeWtxxQAGFGT4vC8ztzwxlSiDYepqiY5vg64QUbRD6qpkJogwfLw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">SMO@PAVmed.com<\/a><\/p>\n<p>Katie Gallagher<br \/>LaVoieHealthScience<br \/>(617) 792-3937<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HmY420RrMV-hBuftOi0iiwWXFWCUxlU8n6bRXlfM2oVFW9lJ2-ax5BWeuhjPqKcx6w07cJQKtT28ecrNMqH1FJ6t2GAlX2zqQDd2rzupb5N0oKIlZKhQ5QeRhyr1NN7s\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">PAVmed@lavoiehealthscience.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/773a9aaf-994a-4cc8-a365-20878663d446\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) &#8212; PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the \u201cCompany\u201d or \u201cPAVmed\u201d), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed\u2019s Chairman and Chief Executive Officer will present a corporate update at the 20th Annual Needham Healthcare Conference on April 15, 2021 at 8:00 AM EDT. To access the live webcast of the presentation, please click here. A replay will be available following the presentation and can be accessed in the Investor Relations section of the PAVmed website. About PAVmed PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company employing a unique business model designed to advance innovative products to commercialization rapidly and with less capital than &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PAVmed to Present at the 20th Annual Needham Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-473705","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PAVmed to Present at the 20th Annual Needham Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PAVmed to Present at the 20th Annual Needham Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) &#8212; PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the \u201cCompany\u201d or \u201cPAVmed\u201d), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed\u2019s Chairman and Chief Executive Officer will present a corporate update at the 20th Annual Needham Healthcare Conference on April 15, 2021 at 8:00 AM EDT. To access the live webcast of the presentation, please click here. A replay will be available following the presentation and can be accessed in the Investor Relations section of the PAVmed website. About PAVmed PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company employing a unique business model designed to advance innovative products to commercialization rapidly and with less capital than &hellip; Continue reading &quot;PAVmed to Present at the 20th Annual Needham Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-08T13:33:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PAVmed to Present at the 20th Annual Needham Healthcare Conference\",\"datePublished\":\"2021-04-08T13:33:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/\"},\"wordCount\":746,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/\",\"name\":\"PAVmed to Present at the 20th Annual Needham Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==\",\"datePublished\":\"2021-04-08T13:33:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PAVmed to Present at the 20th Annual Needham Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PAVmed to Present at the 20th Annual Needham Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"PAVmed to Present at the 20th Annual Needham Healthcare Conference - Market Newsdesk","og_description":"NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) &#8212; PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the \u201cCompany\u201d or \u201cPAVmed\u201d), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed\u2019s Chairman and Chief Executive Officer will present a corporate update at the 20th Annual Needham Healthcare Conference on April 15, 2021 at 8:00 AM EDT. To access the live webcast of the presentation, please click here. A replay will be available following the presentation and can be accessed in the Investor Relations section of the PAVmed website. About PAVmed PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company employing a unique business model designed to advance innovative products to commercialization rapidly and with less capital than &hellip; Continue reading \"PAVmed to Present at the 20th Annual Needham Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-08T13:33:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PAVmed to Present at the 20th Annual Needham Healthcare Conference","datePublished":"2021-04-08T13:33:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/"},"wordCount":746,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/","name":"PAVmed to Present at the 20th Annual Needham Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==","datePublished":"2021-04-08T13:33:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjk4MCM0MTA5OTY4IzUwMDA0OTg1OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pavmed-to-present-at-the-20th-annual-needham-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PAVmed to Present at the 20th Annual Needham Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/473705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=473705"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/473705\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=473705"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=473705"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=473705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}